| 101 |
26056479 | Anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma with involvement of the urinary bladder: a case report and review of literature. | 2015 |
1 |
| 102 |
26137775 | [NON-HODGKIN'S LYMPHOMA OF THE FEMALE GENITAL SYSTEM--A LITERATURE REVIEW]. | 2015 |
1 |
| 103 |
26315113 | Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma. | 2015 Sep 29 |
2 |
| 104 |
26334344 | Role of rituximab in the first-line therapy of high-risk diffuse large B-cell lymphoma: a retrospective analysis by the Polish Lymphoma Research Group. | 2015 |
1 |
| 105 |
26370464 | Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma. | 2015 Sep 14 |
1 |
| 106 |
26376594 | Leuconostoc sp. Meningitis in a Patient Treated with Rituximab for Mantle Cell Lymphoma. | 2015 Sep |
1 |
| 107 |
26458444 | [Diffuse large B-cell lymphoma: therapeutic development based on clinical and biological heterogeneity]. | 2015 Oct |
1 |
| 108 |
26687958 | Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study. | 2015 Apr |
1 |
| 109 |
24180329 | Soluble interleukin-2 receptor level predicts survival in patients with follicular lymphoma treated with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy in the rituximab era. | 2014 Jul |
1 |
| 110 |
24395281 | MALT lymphoma of the small bowel with protein-losing enteropathy. | 2014 Feb |
1 |
| 111 |
24493716 | Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma. | 2014 Apr 10 |
1 |
| 112 |
24612334 | R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma. | 2014 Jul |
1 |
| 113 |
24724408 | [Treatment approaches for diffuse large B-cell lymphoma]. | 2014 Mar |
1 |
| 114 |
24989286 | [Analysis of (18)F-FDG PET/CT features and clinical manifestations in one case of subcutaneous lymphomatoid granulomatosis]. | 2014 Jun |
1 |
| 115 |
25054764 | Case for diagnosis. | 2014 Jul-Aug |
1 |
| 116 |
25197420 | Primary cutaneous γδ-T-cell lymphoma (CGD-TCL) with unilateral lower extremity swelling as first-onset symptom: a rare case report. | 2014 |
1 |
| 117 |
25229255 | Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma. | 2014 Oct 30 |
1 |
| 118 |
25323007 | Annexin A5 inhibits diffuse large B-cell lymphoma cell invasion and chemoresistance through phosphatidylinositol 3-kinase signaling. | 2014 Dec |
2 |
| 119 |
25337281 | A case of post-mogamulizumab relapse of acute-type adult T-cell leukemia/lymphoma successfully treated with mogamulizumab and etoposide. | 2014 |
1 |
| 120 |
22972488 | Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: cost-benefit and quality of life analysis. | 2013 Mar |
1 |
| 121 |
23053189 | Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy. | 2013 Jan |
1 |
| 122 |
23137070 | Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-cell lymphoma receiving doxorubicin-containing chemotherapy. | 2013 Aug |
1 |
| 123 |
23166041 | Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas. | 2013 Feb |
1 |
| 124 |
23578722 | Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial. | 2013 May |
1 |
| 125 |
23615461 | Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles. | 2013 May 25 |
2 |
| 126 |
23636313 | Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab. | 2013 Oct |
1 |
| 127 |
23846384 | Angioimmunoblastic T-cell lymphoma with intramedullary production of platelet-derived growth factor and possibly complicating myelofibrosis: report of a case with review of the literature. | 2013 Aug |
1 |
| 128 |
23996885 | [Interstitial pneumonia connected with rituximab therapy--case report]. | 2013 |
1 |
| 129 |
24143112 | Fludarabine-based versus CHOP-like regimens with or without rituximab in patients with previously untreated indolent lymphoma: a retrospective analysis of safety and efficacy. | 2013 |
1 |
| 130 |
24200545 | Primary hepatic lymphoma: A case report. | 2013 |
1 |
| 131 |
24649228 | Impact of dexamethasone, etoposide, ifosfamide and carboplatin as concurrent chemoradiotherapy agents for nasal natural killer/T-cell lymphoma. | 2013 Jul |
1 |
| 132 |
21460380 | R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group. | 2012 Jan |
1 |
| 133 |
21864040 | Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older. | 2012 Jan |
1 |
| 134 |
22035416 | High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone. | 2012 May |
1 |
| 135 |
22260632 | Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature. | 2012 Jan 19 |
2 |
| 136 |
22333190 | CD5-positive marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) of the lung. | 2012 Feb 14 |
1 |
| 137 |
22721383 | Concurrent administration of rituximab and CHOP chemotherapeutic agents for outpatients with CD20-positive lymphoma. | 2012 Sep |
1 |
| 138 |
22752193 | The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma. | 2012 Nov |
1 |
| 139 |
22759738 | Maintenance therapy in diffuse large B-cell lymphoma. | 2012 Sep |
1 |
| 140 |
22864129 | Sub-acute demyelinating polyradiculoneuropathy as an initial symptom of peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). | 2012 |
1 |
| 141 |
22865806 | A neurological presentation of intravascular B-cell lymphoma. | 2012 Aug 2 |
1 |
| 142 |
22983648 | Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients. | 2012 Nov |
1 |
| 143 |
22997596 | Primary renal lymphoma: long-term results of two patients treated with a chemotherapy + rituximab protocol. | 2012 |
1 |
| 144 |
23267908 | [Four cases of airway obstruction successfully treated by airway stenting]. | 2012 Nov |
1 |
| 145 |
23267962 | [A case of primary hepatic malignant lymphoma accompanied by cholecystitis]. | 2012 Nov |
1 |
| 146 |
23323070 | Pathophysiology and molecular aspects of diffuse large B-cell lymphoma. | 2012 |
1 |
| 147 |
23814970 | [Isolated central nervous system relapse of diffuse large B-cell lymphoma in the era of immunochemotherapy]. | 2012 Dec |
1 |
| 148 |
20354901 | Acute kidney injury secondary to renal large B-cell lymphoma: role of early renal biopsy. | 2011 Mar |
1 |
| 149 |
21257672 | Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressive B-cell lymphomas. | 2011 Aug |
1 |
| 150 |
21323512 | Akt, 14-3-3ζ, and vimentin mediate a drug-resistant invasive phenotype in diffuse large B-cell lymphoma. | 2011 May |
1 |